IL-2 Responsiveness of CD4 and CD8 lymphocytes: Further investigations with human IL-2Rβ transgenic mice

International Immunology

Volumn 17, Issue 8, 2005, Pages 1093-1102

  Gesbert, Franck ^a   Morau, Jean Louis ^a   Thèze, Jacques ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

Cellular proliferation; Cytokine cytokine receptors; T lymphocytes; Transgenic mice

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL CULTURE; CELL CYCLE G1 PHASE; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CULTURE MEDIUM; CYTOTOXICITY; GENE FUNCTION; GROWTH INHIBITION; MONOCYTE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SPLEEN CELL; TRANSGENIC MOUSE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL CYCLE; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; GENE EXPRESSION; HUMANS; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR BETA SUBUNIT; KILLER CELLS, NATURAL; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RECEPTORS, INTERLEUKIN; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

EID: 23844460275     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/dxh289     Document Type: Article

References (53)

1. Taniguchi, T., Matsui, H., Fujita, T. et al. 1983. Structure and expression of a cloned cDNA for human interleukin-2. Nature 302:305.
2. Smith, K. A. 1988. Interleukin-2: Inception, impact, and implications. Science 240:1169.
3. Theze, J., Alzari, P. M. and Bertoglio, J. 1996. Interleukin 2 and its receptors: Recent advances and new immunological functions. Immunol. Today 17:481.
4. Lenardo, M. J. 1991. Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature 353:858.
5. Refaeli, Y., Van Parijs, L., London,C. A., Tschopp, J. and Abbas, A. K. 1998. Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity 8:615.
6. Chastagner, P., Reddy, J. and Theze, J. 2002. Lymphoadenopathy in IL-2-deficient mice: Further characterization and overexpression of the antiapoptotic molecule cellular FLIP. J. Immunol. 169:3644.
7. Malek, T. R. 2003. The main function of IL-2 is to promote the development of T regulatory cells. J. Leukoc. Biol. 2:2.
8. Uchiyama, T., Broder, S. and Waldmann, T. A. 1981. A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells. J. Immunol. 126:1393.
9. Leonard, W. J., Depper, J. M., Crabtree, G. R. et al. 1984. Molecular cloning and expression of cDNAs for the human interleukin-2 receptor. Nature 311:626.
10. Teshigawara, K., Wang, H. M., Kato, K. and Smith, K. A. 1987. Interleukin 2 high-affinity receptor expression requires two distinct binding proteins. J. Exp. Med. 165:223.
11. Hatakeyama, M., Tsudo, M., Minamoto, S. et al. 1989. Interleukin-2 receptor beta chain gene: Generation of three receptor forms by cloned human alpha and beta chain cDNA's. Science 244:551.
12. Tsudo, M., Kitamura, F. and Miyasaka, M. 1989. Characterization of the interleukin 2 receptor beta chain using three distinct monoclonal antibodies. Proc. Natl Acad. Sci. USA 86:1982.
13. Takeshita, T., Asao, H., Ohtani, K. et al. 1992. Cloning of the gamma chain of the human IL-2 receptor. Science 257:379.
14. Kumaki, S., Kondo, M., Takeshita, T., Asao, H., Nakamura, M. and Sugamura, K. 1993. Cloning of the mouse interleukin 2 receptor gamma chain: Demonstration of functional differences between the mouse and human receptors. Biochem. Biophys. Res. Commun. 193:356.
15. Chastagner, P., Moreau, J. L., Jacques, Y. et al. 1996. Lack of intermediate-affinity interleukin-2 receptor in mice leads to dependence on interleukin-2 receptor alpha, beta and gamma chain expression for T cell growth. Eur. J. Immunol. 26:201.
16. Karnitz, L. M. and Abraham, R. T. 1996. Interleukin-2 receptor signaling mechanisms. Adv. Immunol. 61:147.
17. Gesbert, F., Delespine-Carmagnat, M. and Bertoglio, J. 1998. Recent advances in the understanding of interleukin-2 signal transduction. J. Clin. Immunol. 18:307.
18. Leonard, W. J. and O'Shea, J. J. 1998. Jaks and STATs: Biological implications. Annu. Rev. Immunol. 16:293.
19. Lin, J. X. and Leonard, W. J. 2000. The role of Stat5a and Stat5b in signaling by IL-2 family cytokines.Oncogene 19:2566.
20. Ellery, J. M. and Nicholls, P. J. 2002. Alternate signalling pathways from the interleukin-2 receptor. Cytokine Growth Factor Rev. 13:27.
21. Moreau, J. L., Chastagner, P., Tanaka, T. et al. 1995. Control of the IL-2 responsiveness of B lymphocytes by IL-2 and IL-4. J. Immunol. 155:3401.
22. Gullberg, M. and Smith, K. A. 1986. Regulation of T cell autocrine growth. T4+ cells become refractory to interleukin 2. J. Exp. Med. 163:270.
23. Asano, M., Ishida, Y., Sabe, H., Kondo, M., Sugamura, K. and Honjo, T. 1994. IL-2 can support growth of CD8+ T cells but not CD4+ T cells of human IL-2 receptor beta-chain transgenic mice. J. Immunol. 153:5373.
24. Suwa, H., Tanaka, T., Kitamura, F., Shiohara, T., Kuida, K. and Miyasaka, M. 1995. Dysregulated expression of the IL-2 receptor beta-chain abrogates development of NK cells and Thy-1+ dendritic epidermal cells in transgenic mice. Int. Immunol. 7:1441.
25. Ku, C. C., Murakami, M., Sakamoto, A., Kappler, J. and Marrack, P. 2000. Control of homeostasis of CD8+ memory T cells by opposing cytokines. Science 288:675.
26. Demaison, C., Fiette, L., Blanchetiere, V., Schimpl, A., Theze, J. and Froussard, P. 1998. IL-2 receptor alpha-chain expression is independently regulated in primary and secondary lymphoid organs. J. Immunol. 161:1977.
27. Sherr, C. J. and Roberts, J. M. 1999. CDK inhibitors: Positive and negative regulators of G1-phase progression. Genes Dev. 13:1501.
28. Coqueret, O. 2003. New roles for p21 and p27 cell-cycle inhibitors: A function for each cell compartment? Trends Cell Biol. 13:65.
29. Bismuth, G., Moreau, J. L., Somme, G. et al. 1985. Regulation of interleukin 2 (IL2) receptor expression: IL2 as an inducing signal for the expression of its own receptor on a murine T helper cell line. Eur. J. Immunol. 15:723.
30. Malek, T. R. and Ashwell, J. D. 1985. Interleukin 2 upregulates expression of its receptor on a T cell clone. J. Exp. Med. 161:1575.
31. Smith, K. A. and Cantrell, D. A. 1985. Interleukin 2 regulates its own receptors. Proc. Natl Acad. Sci. USA 82:864.
32. Depper, J. M., Leonard, W. J., Drogula, C., Kronke, M., Waldmann, T. A. and Greene, W. C. 1985. Interleukin 2 (IL-2) augments transcription of the IL-2 receptor gene. Proc. Natl Acad. Sci. USA 82:4230.
33. Ishii, N., Takeshita, T., Kimura, Y. et al. 1994. Expression of the IL-2 receptor gamma chain on various populations in human peripheral blood. Int. Immunol. 6:1273.
34. Nakarai, T., Robertson, M. J., Streuli, M. et al. 1994. Interleukin 2 receptor gamma chain expression on resting and activated lymphoid cells. J. Exp. Med. 180:241.
35. Bani, L., Pasquier, V., Kryworuchko, M., Salamero, J. and Theze, J. 2001. Unstimulated human CD4 lymphocytes express a cytoplasmic immature form of the common cytokine receptor gammachain. J. Immunol. 167:344.
36. Demaison, C., Chastagner, P., Moreau, J. L. and Theze, J. 1996. Ligand-induced autoregulation of IL-2 receptor alpha chain expression in murine T cell lines. Int. Immunol. 8:1521.
37. Pitton, C., Rebollo, A., Van Snick, J., Theze, J. and Garcia, A. 1993. High-affinity and intermediate-affinity forms of the human interleukin 2 receptor, expressed in an interleukin 9-dependent murine T cell line, deliver proliferative signals via differences in their transduction pathways. Cytokine 5:362.
38. Herblot, S., Chastagner, P., Samady, L. et al. 1999. IL-2-dependent expression of genes involved in cytoskeleton organization, oncogene regulation, and transcriptional control. J. Immunol. 162:3280.
39. Beadling, C. and Smith, K. A. 2002. DNA array analysis of interleukin-2-regulated immediate/early genes. Med. Immunol. 1:2.
40. Kovanen, P. E., Rosenwald, A., Fu, J. et al. 2003. Analysis of gamma c-family cytokine target genes. Identification of dual-specificity phosphatase 5 (DUSP5) as a regulator of mitogen-activated protein kinase activity in interleukin-2 signaling. J. Biol. Chem. 278:5205.
41. Malek, T. R., Yu, A., Scibelli, P., Lichtenheld, M. G. and Codias, E. K. 2001. Broad programming by IL-2 receptor signaling for extended growth to multiple cytokines and functional maturation of antigen-activated T cells. J. Immunol. 166:1675.
42. Malek, T. R. 2002. T helper cells, IL-2 and the generation of cytotoxic T-cell responses. Trends Immunol. 23:465.
43. Wong, P. and Pamer, E. G. 2001. Cutting edge: Antigen-independent CD8 T cell proliferation. J. Immunol. 166:5864.
44. Foulds, K. E., Zenewicz, L. A., Shedlock, D. J., Jiang, J., Troy, A. E. and Shen, H. 2002. Cutting edge: CD4 and CD8 T cells are intrinsically different in their proliferative responses. J. Immunol. 168:1528.
45. Gasser, S., Corthesy, P., Beerman, F., MacDonald, H. R. and Nabholz, M. 2000. Constitutive expression of a chimeric receptor that delivers IL-2/ IL-15 signals allows antigen-independent proliferation of CD8+CD44high but not other T cells. J. Immunol. 164:5659.
46. Dhanji, S. and Teh, H. S. 2003. IL-2-Activated CD8(+)CD44(high) cells express both adaptive and innate immune system receptors and demonstrate specificity for syngeneic tumor cells. J. Immunol. 171:3442.
47. Rosenberg, S. A., Lotze, M. T., Muul, L. M. et al. 1985. Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N. Engl. J. Med. 313:1485.
48. Kovacs, J. A., Vogel, S., Albert, J. M. et al. 1996. Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus. N. Engl. J. Med. 335:1350.
49. Jacobson, E. L., Pilaro, F. and Smith, K. A. 1996. Rational interleukin 2 therapy for HIV positive individuals: Daily low doses enhance immune function without toxicity. Proc. Natl Acad. Sci. USA 93:10405.
50. Davey, R. T., Jr, Murphy, R. L., Graziano, F. M. et al. 2000. Immunologic and virologic effects of subcutaneous interleukin 2 in combination with antiretroviral therapy: A randomized controlled trial. JAMA 284:183.
51. David, D., Nait-Ighil, L., Dupont, B., Maral, J., Gachot, B. and Theze, J. 2001. Rapid effect of interleukin-2 therapy in human immunodeficiency virus-infected patients whose CD4 cell counts increase only slightly in response to combined antiretroviral treatment. J. Infect. Dis. 183:730.
52. Sereti, I., Martinez-Wilson, H., Metcalf, J. A. et al. 2002. Long-term effects of intermittent interleukin 2 therapy in patients with HIV infection: Characterization of a novel subset of CD4(+)/CD25(+) T cells. Blood 100:2159.
53. Blattman, J. N., Grayson, J. M., Wherry, E. J., Kaech, S. M., Smith, K. A. and Ahmed, R. 2003. Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo. Nat. Med. 9:540.